>>> US After Hours Summary: SANM +3.8% and BRO +2.9% up modestly on earnings; EL

After Hours Summary: SANM +3.8% and BRO +2.9% up modestly on earnings; ELS -6% and GGG -5.5% tick lower following quarterly numbers

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: SBCF +4.2%, SANM +3.8% (also increases buyback plan by $300 mln), BRO +2.9%, WRB +1.6%, NUE +0.6%, GIS +0.6% (also completes sale of its Canadian Yogurt business), WSFS +0.5%, CR +0.5% (also increases dividend)

Companies trading higher in after hours in reaction to news: HESM +3.6% (increases dividend), CLPT +2.9% (FDA clearance for ClearPoint Navigation Software), BWXT +2.1% (contracts of over C$1 bln for two nuclear energy projects), LW +1.6% (JANA Partners sends letter to LW), HWM +1.5% (increases dividend), TLN +1.1% (reach reliability must run settlement agreement), TKC +0.5% (Paycell LLC to be liquidated), ET +0.5% (increases dividend), APLS +0.1% (approval of SYFOVRE), GOOS +0.1% (renews regulatory relief regarding repurchase program), GE +0.1% (awarded $3.5 bln U.S. Air Force contract mod LMT +0.1% (awarded $502 mln U.S. Navy contract), SKYH +0.1% (stock offering)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: SFBS -6.2%, ELS -6%, GGG -5.5%, TRNS -4.9%, WAL -2.2%, AGNC -1.1%, MRTN -0.8%, EG -0.8%, ARE -0.6%

Companies trading lower in after hours in reaction to news: ETNB -2.4% ($250 mln stock offering), BLTE -1.9% (files mixed shelf), WTRG -1.6% (awarded $29 mln in funding to remove PFAS), QMCO -0.7% (stock offering), PSN -0.3% (SealingTech delivers over 500 Cyber-Fly-Away kits), SPXC -0.1% (completes acqusition of Kranze Technology Solutions)

>>> US Close Dow +0.65% S&P -1.46% Nasdaq -3.07% Russell -1.03%

Closing Stock Market Summary
The stock market was mixed today. Big tech stocks, semiconductor-related names, and utility shares with AI exposure registered outsized declines while money rotated to other areas of the market.

NVIDIA (NVDA 118.42, -24.20, -17.0%) logged its largest single-day loss in market capitalization ever, driven by concerns over China's DeepSeek AI model. This AI model attracted attention after it was perceived as much more cost-effective than U.S. alternatives, such as OpenAI's ChatGPT.

The potential of DeepSeek to challenge the competitiveness of leading U.S. AI players raised questions about the future direction of the sector, particularly if DeepSeek can deliver on its promises. In response, the PHLX Semiconductor Index (SOX) has plummeted 9.2%, as investors reassess capital spending plans.

This weakness did not leak into the "rest" of the equity market as AI exuberance that led many names sharply higher was rung out of the market. More S&P 500 sectors closed higher (six) than lower (five).

The Dow Jones Industrial Average rose 0.7%, with 20 of its 30 components in the green. Meanwhile, the equal-weighted S&P 500 eked out a 0.1% gain, in contrast to the 1.5% drop in the market-cap weighted index. Market breadth was also more positive at the NYSE, where advancing issues lead decliners by a 3-to-2 ratio, though decliners outpace advancers at the Nasdaq by a 3-to-2 margin.

Still, the flight to safety impacted in the fixed-income market. The 10-year yield dropped ten basis points to 4.53% and the 2-year yield fell eight basis points to 4.19%. Also, today's $69 billion 2-yr note sale met tepid demand and a $70 billion 5-yr note offering garnered stronger interest than the 2-yr sale.

Investor caution was also palpable ahead of a busy earnings week, with around 40% of the S&P 500 by market capitalization set to report. Among them are two of the three $3 trillion companies—Apple (AAPL 229.86, +7.08, +3.2%) and Microsoft (MSFT 434.56, -9.50, -2.1%).
  • Dow Jones Industrial Average: +5.1% YTD
  • S&P Midcap 400: +3.8% YTD
  • S&P 500: +2.2% YTD
  • Russell 2000: +2.4% YTD
  • Nasdaq Composite: +0.2% YTD

eviewing today's economic data:
  • December New Home Sales 698K (consensus 680K); Prior was revised to 674K from 664K
    • The key takeaway from the report is that new home sales growth was ahead of expectations in December, but selling prices jumped from the bottom of the range that was seen in 2024 toward the top, which presents a headwind to selling activity going forward.

Looking ahead to Tuesday, market participants receive the following economic data:
  • 8:30 ET: December Durable Orders (consensus 0.4%; prior -1.1%) and Durable Orders ex-transport (consensus 0.5%; prior -0.1%)
  • 9:00 ET: November FHFA Housing Price Index (prior 0.4%) and November S&P Case-Shiller Home Price Index (Briefing.com consensus 4.2%; prior 4.2%)
  • 10:00 ET: January Consumer Confidence (consensus 108.1; prior 104.7)

WSJ : Vail Resorts Shareholder Calls for Overhaul, Ouster of Executives Includin

Vail Resorts Shareholder Calls for Overhaul, Ouster of Executives Including CEO
Late Apex says Vail should reset board, cut dividend by 80% and hire a proven CEO

Scrutiny around Vail Resorts MTN 3.51%increase; green up pointing triangle is growing.

Late Apex Partners, whose funds currently own shares in the hospitality company, said in a letter that Vail’s performance over the last five years has been unacceptable.

“We believe Vail is fixable, but the board must act now to hold management accountable,” Late Apex said. The financial firm noted its investment in Vail is its single largest position.

Late Apex criticized Vail’s key performance indicators, insider compensation incentives, capital allocation strategy and balance sheet management.

The firm called for the ouster of Chief Executive Kirsten Lynch, Chief Financial Officer Angela Korch and Executive Chairman Rob Katz. It also said Vail should reset its board, cut its dividend by 80% and hire a proven CEO.

Vail didn’t immediately respond to a request for comment.

Vail’s troubles have been brewing for some time. The company recently disclosed it sold fewer season lift tickets than it did the year before. A 12-day ski-patrol strike closed most runs at Park City, Utah, infuriating customers. Competitors have also introduced rival multi-resort megapasses that function similar to Vail’s Epic Pass, which offers unlimited access to 42 Vail properties around the world.

Shares rose 2% to $170 Monday. The stock is down roughly 23% over the last year and around 54% from its all-time closing high of $372.51 in November 2021.

The Information : The Electric: Humanoid Robots Are Cool—but How Will Their Batt

The Electric: Humanoid Robots Are Cool—but How Will Their Battery Problem Be Solved?

Adam Jonas made his name as one of the biggest Tesla bulls. These days, people are flooding the Morgan Stanley analyst with questions about humanoid robots. The volume of calls has exceeded “the entirety of our [automaker], dealer and supplier coverage combined,” he said in a note Friday.

Tesla’s Optimus robots likely sparked the enthusiasm for humanoids among Jonas’ clients. At a Tesla event in October, a dozen or so prototypes operated by staff behind the scenes served drinks and gabbed with amused guests. CEO Elon Musk, presiding over the event, said Optimus would “basically do anything you want,” and that future sales of the robot would drive Tesla’s value to $25 trillion.

Jonas is not convinced. Robot sales are not part of his forecast demand model, which goes through 2040. Though he did not cite battery life as a reason, it’s a key problem.

Battery power, it turns out, is a primary limiting factor in the deployment of humanoids: A small number of humanoid robots now work in factories. They have a runtime of only about an hour and a half when they’re carrying stuff and moving around.

It then takes up to an hour to recharge them. That means a factory or warehouse would have to keep two or more robots on hand for each task, swapping them out for recharging. “It’s a major hurdle for humanoids to actually be a realistic tool for any business that is looking to add them to their operation,” said Steve Crowe, editor of The Robot Report. “They need to figure out how to make the batteries last longer.”

Roughly 4 million industrial robots were in operation globally last year, of which some 382,000 were in the U.S., according to the International Federation of Robotics. Almost none were humanoids. Instead, most sat in one place and remained plugged in, or they moved on wheels, which is far more efficient than walking around.

In the U.S., there is at least one humanoid robot working under a paid contract. Digit, made by Oregon-based Agility Robotics, can carry around 30 pounds of stuff in its arms. Some Digits are now moving merchandise around a Spanx apparel distribution warehouse in Flowery Branch, Ga.

Agility’s engineers have tried hard to maximize Digit’s battery life. They’ve packed as many cylindrical batteries as they could into the robot’s torso, Agility chief technology officer Pras Velagapudi told me. The batteries are nickel-manganese-cobalt with graphite anodes—among the densest chemistries in current lithium-ion batteries. Still, the robots can work for just one and a half to two hours on a charge. It takes 50 minutes to an hour to get them back to a full charge, he said

For now, Velagapudi said, his focus is on making the charging process as fast as possible: The goal is to get Digit to charge in, say, 10 minutes, and then work for 100 minutes. In that case, total runtime matters less. The robots could charge while humans take their breaks, he said.

The Digit drains its batteries most quickly when it is carrying heavy things. Some of that is offset by power generated when the robot walks and swings its arms. It’s similar to regenerative braking in an electric vehicle.

“It’s not necessarily about running forever,” Velagapudi said. “It’s about running for a long time with respect to how much you’re charging to get an overall good, useful amount of work out of the robot over time.”

Velagapudi gave limited details about Agility’s future strategy. When I asked whether the company planned to use silicon anodes, which would allow superfast charging and could also increase Digit’s working time, he said only that he’d consider anything as long as it doesn’t surpass the robot’s weight and mass maximums.

While the need is great, the battery industry has been slow to respond: Since the Tesla event, I’ve asked multiple battery startup executives about humanoid power requirements. Earlier this month, as we reported, SES AI CEO Qichao Hu released a prototype battery with silicon that he said could power robotics, though he did not mention humanoids; none of the other CEOs had reached out to robot developers to find out what they needed.

Battery developers have eagerly pursued other futuristic uses besides EVs for their products, including powering space-going satellites and flying electric taxis. With EV demand sluggish in the U.S. and Europe, automakers appear to be less interested in deploying next-generation batteries; the developers of silicon and lithium-metal batteries need new markets.

If Musk is right about future demand, humanoids are a rich new opportunity. Crowe, the newsletter editor, said some humanoid prototypes have three hours of uptime, but that that’s not enough either. It’s a major issue for the nascent industry. “A three-hour battery life is not really acceptable,” he said.

TechCrunch : DeepSeek gets Silicon Valley talking

DeepSeek gets Silicon Valley talking

Since Chinese AI company DeepSeek released an open version of its reasoning model R1 at the beginning of this week, many in the tech industry have been making grand pronouncements about what the company achieved, and what it means for the state of AI.

Venture capitalist Marc Andreessen, for example, posted that DeepSeek is “one of the most amazing and impressive breakthroughs I’ve ever seen.”

R1 seemingly matches or beats OpenAI’s o1 model on certain AI benchmarks. And the company claims one of its models only cost $5.6 million to train, compared to the hundreds of millions of dollars that leading American companies pay to train theirs.

It also seems to have achieved that in the face of U.S. sanctions that prohibit the sale of advanced chips to Chinese companies. The MIT Technology Review writes that the company’s success illustrates how sanctions are “driving startups like DeepSeek to innovate in ways that prioritize efficiency, resource-pooling, and collaboration.” (On the other hand, the Wall Street Journal reports that DeepSeek’s Liang Wenfeng recently told China’s premier that American export restrictions still pose a bottleneck.)

Curai CEO Neal Khosla offered a simpler explanation, claiming that the company is a “ccp state psyop” that’s “faking the cost was low to justify setting price low and hoping everyone switches to it [to] damage AI competitiveness in the us.” (A Community Note has been attached to his post pointing out that Khosla offers no evidence for this, and that his father Vinod is an OpenAI investor.)

Meanwhile, journalist Holger Zschaepitz suggested DeepSeek “could represent the biggest threat to US equity markets” — if a Chinese company can build a cutting-edge model at low cost, without access to advanced chips, it would call into question “the utility of the hundreds of billions worth of capex being poured into this industry.”

In response, Y Combinator CEO Garry Tan argued DeepSeek’s success would actually be good for its American competitors. “If training models get cheaper faster and easier,” he wrote on X, “the demand for inference (actual real world use of AI) will grow and accelerate even faster, which assures the supply of compute will be used.”

And Meta’s Chief AI Scientist Yann LeCun argued against looking at DeepSeek’s announcement through the lens of China versus the United States. Instead, he suggested the real lesson is that “open source models are surpassing proprietary ones.”

“DeepSeek has profited from open research and open source (e.g. PyTorch and Llama from Meta),” LeCun wrote on LinkedIn this week. “They came up with new ideas and built them on top of other people’s work. Because their work is published and open source, everyone can profit from it.”

All of the debate seems to be driving consumers to try the product. As of Sunday afternoon, DeepSeek’s AI assistant is the top free app in the Apple App Store, just ahead of ChatGPT.

>>> Research Calls I

Research Calls I
  • Upgrades:
    • 1st Source Corp (SRCE) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $72.50
    • Apple Hospitality REIT (APLE) upgraded to Buy from Neutral at BofA Securities; tgt raised to $17
    • Aptiv (APTV) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $82
    • British American Tobacco (BTI) upgraded to Buy from Neutral at UBS
    • Burke & Herbert Financial Services Corp. (BHRB) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt lowered to $76
    • Dana Inc (DAN) upgraded to Equal Weight from Underweight at Wells Fargo; tgt raised to $16
    • Exelixis (EXEL) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $40
    • Interpublic (IPG) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $39
    • Portillo's (PTLO) upgraded to Buy from Hold at Stifel; tgt raised to $16
    • Qorvo (QRVO) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $110
    • Redwire Corporation (RDW) upgraded to Buy from Neutral at B. Riley Securities; tgt raised to $27
    • South State (SSB) upgraded to Buy from Neutral at Citigroup; tgt raised to $128
    • State Street (STT) upgraded to Peer Perform from Underperform at Wolfe Research
    • Take-Two (TTWO) upgraded to Buy from Neutral at UBS; tgt raised to $230
    • Titan Machinery (TITN) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $25
    • Travel + Leisure Co (TNL) upgraded to Buy from Underperform at BofA Securities; tgt raised to $60
    • Twilio (TWLO) upgraded to Buy from Neutral at Goldman; tgt raised to $185
    • Waste Mgmt (WM) upgraded to Sector Outperform from Sector Perform at Scotiabank; tgt raised to $250
  • Downgrades:
    • Air Products (APD) downgraded to Neutral from Buy at BofA Securities; tgt $350
    • Ameren (AEE) downgraded to Equal Weight from Overweight at Barclays; tgt raised to $95
    • Barrick (GOLD) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $18
    • Bloomin' Brands (BLMN) downgraded to Underperform from Neutral at BofA Securities; tgt $13
    • D.R. Horton (DHI) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $150
    • Fannie Mae (FNMA) downgraded to Underperform from Mkt Perform at Keefe Bruyette; tgt raised to $4
    • Freddie Mac (FMCC) downgraded to Underperform from Mkt Perform at Keefe Bruyette; tgt raised to $4.50
    • Intellia Therapeutics (NTLA) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $11
    • Public Service (PEG) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $84
    • RingCentral (RNG) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $37
    • RLI Corp (RLI) downgraded to Underperform from Buy at Jefferies; tgt lowered to $61
  • Others:
    • American Tower (AMT) initiated with a Mkt Outperform at JMP Securities; tgt $225
    • Ares Management (ARES) resumed with an Overweight at Barclays; tgt $224
    • Bitdeer Technologies (BTDR) initiated with an Outperform at Keefe Bruyette; tgt $26.50
    • CleanSpark (CLSK) initiated with an Outperform at Keefe Bruyette; tgt $19
    • Core Scientific (CORZ) initiated with an Outperform at Keefe Bruyette; tgt $22
    • Crown Castle (CCI) initiated with a Mkt Outperform at JMP Securities; tgt $115
    • DigitalBridge (DBRG) initiated with a Mkt Outperform at JMP Securities; tgt $16
    • Digital Realty Trust (DLR) initiated with a Mkt Outperform at JMP Securities; tgt $220
    • Equinix (EQIX) initiated with a Mkt Outperform at JMP Securities; tgt $1200
    • GDS Holdings (GDS) initiated with a Mkt Outperform at JMP Securities; tgt $35
    • GFL Environmental (GFL) initiated with a Buy at Citigroup; tgt $53
    • Marvell (MRVL) initiated with a Buy at Melius; tgt $188
    • Palladyne AI (PDYN) initiated with a Buy at Alliance Global Partners; tgt $15
    • Sagimet Biosciences (SGMT) initiated with a Buy at JonesResearch
    • SBA Comm (SBAC) initiated with a Mkt Outperform at JMP Securities; tgt $250
    • Vistra Corp. (VST) resumed with a Neutral at BofA Securities; tgt $206

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • T +2.1%, SBGI +1.3%
Other news:
  • AKRO +110.7% (reports preliminary topline results showing statistically significant reversal of compensated cirrhosis due to MASH—by both completer and ITT analyses—at Week 96 in phase 2b symmetry study)
  • TVGN +37.8% (Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure)
  • DADA +26.2% (announces receipt of a preliminary non-binding proposal to acquire the company)
  • LGTY +23.8% (to be acquired by Aptean for $14.30 per share)
  • SOR +14% (Proposes Merger With 180 Degree Capital Corp)
  • IPHA +10.2% (Announces First Patient Dosed in Phase 1 Study of Its Nectin-4 Targeting Antibody Drug Conjugate IPH4502 in Selected Advanced Solid Tumors)
  • ADAG +3.1% (Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA)
  • AZPN +3% (Aspen Tech to be acquired by Emerson for $265.00 per share)
  • RNAC +3% (received written agreement from the U.S. FDA under the Special Protocol Assessment process on the overall design of the Company's planned Phase 3 AURORA trial for Descartes-08, its lead mRNA cell therapy candidate, in myasthenia gravis)
  • DEC +2.3% (enters into a definitive agreement to acquire Maverick Natural Resources, a portfolio company of EIG for total consideration of approximately $1,275 mln)
  • DVAX +2% (advances board refreshment program)
  • GSK +1.7% (Shingrix new prefilled syringe presentation accepted for review by EMA)
  • AWK +1.5% (Pennsylvania American Water receives $19.3 mln in PENNVEST funding to make water and wastewater infrastructure improvements)
  • BMY +1.5% (Presents Results from CheckMate -8HW Analysis Evaluating Opdivo® (nivolumab) plus Yervoy (ipilimumab) Compared to Opdivo Monotherapy)
  • EMCG +1.3% (announces entering into a definitive merger agreement with Tianji)
  • EXEL +1.2% (Announces Encouraging Results from Phase 1b/2 STELLAR-001 Trial Evaluating Zanzalintinib Alone or in Combination with an Immune Checkpoint Inhibitor in Metastatic Colorectal Cancer at ASCO GI 2025)

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • SOFI -11.8%
Select Index ETFs showing weakness:
  • QQQ -3.8%, SPY -2.2%, IWM -1.2%, DIA -0.9%
Select tech names showing early weakness:
  • NVDA -12.1%, ARM -10.5%, MSFT -6%, AI -5.7%, XLK -4.8%, AMD -4.4%, META -3.4%
Other news:
  • VERU -38.8% (Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY (Semaglutide) for Weight Reduction)
  • MVST -15.1% (files for $250 mln mixed securities shelf offering)
  • KULR -6.5% (increased the maximum offering amount of the shares issuable under the At The Market Offering Agreement to $100,000,000 from $50,000,000; filed a prospectus supplement under the Sales Agreement for an aggregate of $50 mln)
  • MSTR -5.6% (sold an aggregate of 2,765,157 Shares under the Sales Agreement during the period between January 21, 2025 and January 26, 2025)
  • ECOR -3.5% (files $100 mln mixed shelf securities offering)
  • NTRA -3.3% (Phase III CALGB (Alliance) / SWOG 80702 Clinical Trial in Colorectal Cancer)
  • KOPN -3% (enters into $50 mln At-The-Market Equity Offering Sales Agreement)
  • PRTC -2.5% (Founded Vedanta Biosciences Publishes Additional Phase 2 VE303 Results in Nature Medicine)
  • SLDB -2.5% (provided DOE update)
  • SRPT -1.7% (Announces Results from Part 2 of the EMBARK Study Demonstrating Sustained Benefits and Disease Stabilization in Ambulatory Individuals with Duchenne Muscular Dystrophy Following Treatment with ELEVIDYS)
  • X -1.7% (reiterates commitment to maximizing value for stockholders; issues statement in response to Ancora)
  • HTH -1.7% (announces agreement to sell its interest in Moser Energy Systems)
  • MIDD -1% (confirms ongoing strategic review of business portfolio as part of Board of Directors' efforts to maximize shareholder value)

FT : Venture Global’s IPO stumble shows the limits of gassing up a valuation

Venture Global’s IPO stumble shows the limits of gassing up a valuation
Pitch in poetry, execute in prose

In financial markets, as in life, the line between ambition and delusion is often perilously thin. The recent IPO of liquid natural gas exporter Venture Global is a textbook example of how even the most promising prospects can unravel when investor scepticism clashes with sky-high valuation ambitions. What started as a confident march, fuelled by Trump-era energy optimism and the allure of a booming LNG export market, swiftly turned into a cautionary tale, courtesy of the equity capital markets.

The stars had seemed aligned. US equity markets have been on a tear. The incoming administration has vigorously promoted natural gas and promised to rescind the Department of Energy’s pause on LNG exports. Against this positive backdrop, Venture Global aimed for the stratosphere, setting a valuation range for a $2.3bn IPO at $40-$46 per share — implying a fully diluted market cap of $125bn.

But even in this bulled-up era, markets don’t run on pixie dust alone. Investors balked at the company’s assumptions, starting with its valuation of future cash flows from five LNG terminals — of which only one is operational and another is nearing completion. Fund managers also pushed back on assumptions of a $6 per million British thermal unit spread on LNG sales, noting much of the output hadn’t yet been contracted. A mere 1.9 per cent free float also left many potential buyers concerned. And then there was the legal quagmire: multibillion-dollar arbitration claims from BP, Shell, and others, alleging that Venture Global had reneged on its contractual obligations by selling LNG on the spot market. 

Despite pressure from the underwriters, investors held firm: in their view, Venture Global could not justify an over 30 per cent premium on a forward EV/ebitda basis compared to its more established peer, Cheniere Energy, which many of the targeted fund managers know well and already own. Even in hot markets, investors expect an IPO discount.

Faced with mounting concerns, the IPO was dramatically reworked, with its valuation slashed by a jaw-dropping 42 per cent. The shares priced at $25, at the midpoint of a revised $23-27 range, raising $1.75bn. This amounted to a humbling climbdown, exposing the chasm between boardroom bravado and unforgiving market judgments.

How did the bankers and management get the terms so wrong? In fact, these kinds of misjudgments aren’t all that uncommon — and they’re not that easy to avoid! 

One possible culprit is the investment banking ecosystem. Banks operate in a world where success is measured in mandates secured and fees earned. Winning an IPO pitch often hinges on presenting the most compelling (read: optimistic) valuation. In the world of equity capital markets, the mantra might as well be: “Pitch in poetry, execute in prose.” When courting clients, bankers float punchy numbers with just enough plausibility to preserve credibility. 

A lower valuation might be more realistic, but it won’t win you the mandate. Every equity capital markets banker — and I mean every — can tell a plaintive story about losing a big IPO pitch because the mooted valuation in the presentation deck was below those of other banks. Of course, no client tells a spurned bank that their numbers were too conservative; the euphemisms are always about “misunderstanding the story” or failing to grasp “growth potential.” But you get the point.

Venture Global’s leadership may have played its part too. In my experience, founders and executives at companies like these are often charismatic, visionary risk-takers — people who’ve thrived by zigging when others zagged. Their confidence, the very quality that fuels their success, can also make them resistant to advice that feels like a brake on their momentum. Telling phenomenally successful entrepreneurs that their brainchild is worth less than they think is not for the faint of heart. It’s also possible the banks, under pressure to keep the client happy, didn’t push back hard enough on the company’s valuation expectations. I’ve seen this happen time and again.

All that said, one common reason for an IPO re-pricing or withdrawal is not present here. Sometimes the stock market falls during the marketing process, rendering what seemed like a reasonable price range suddenly untenable. But that wasn’t the case here. If anything, the Trump-era enthusiasm created a frothy environment. Yet investors still have their limits. Venture Global discovered, the hard way, that not every story — no matter how aligned with the Zeitgeist — commands a premium price.

So what’s the big deal about repricing an IPO? After all, isn’t price discovery part of the process? Technically, yes. But the cost is still significant. A downward repricing isn’t just a financial adjustment; it’s a psychological blow. Momentum shifts. The narrative evolves from “hot-ticket” to “let’s wait and see.” The company loses pricing leverage, while investors take the upper hand. Indeed, two large fund managers told me on Friday they would have participated at $27-30 per share, whereas the offering ended up pricing at $25.

So for Venture Global, the fallout extends beyond wounded pride and temporary embarrassment. Raising capital under less favourable terms is a tangible setback.

The stock stumbled out of the gate, closing down 4 per cent on Friday at $24. While no one can say for certain, it’s worth asking whether a lower initial price range might have avoided a rocky start. The repricing cast a shadow over the deal’s dynamics, and the flagrantly unrealistic nature of the first price range — coupled with an aggressive campaign to convince investors that other fund managers supported it (“Gaslighting at its finest,” one investor told MainFT) — may have sown doubts about other management claims that might otherwise have been accepted at face value. With strong market tailwinds, this offering had the potential to be a blockbuster; instead, Venture Global’s market debut landed with the grace and buoyancy of a deflated balloon.

However, not all is lost. Cutting an IPO price range is sometimes just a hiccup; some companies have weathered the experience and thrived. Google famously priced its 2004 IPO at $85 after starting with a $108-135 range, and the rest, as they say, is history.

More generally, markets have a way of recalibrating, and Venture Global’s IPO offers a nuanced lesson. It’s a reminder that valuations aren’t fixed by management or banker decree, but rather hammered out in the back-and-forth with investors. 

The key takeaway from Venture Global’s market debut is clear: investors are willing to pay a premium valuation, but only if the financials justify it today — not based on the hope that the company might enter a higher-growth phase two or three years down the line.

Even in these optimistic markets, there’s a boundary between visionary thinking and valuation credibility. Venture Global’s down-priced, downsized offering is not a negative omen for the IPO market, but a reality check at a time of market excess elsewhere.

FT : Tesla sues EU over tariffs on electric vehicles from China

Tesla sues EU over tariffs on electric vehicles from China
Decision marks latest confrontation between Elon Musk and Brussels

Tesla is suing the EU over tariffs the bloc imposed on imports of electric vehicles from China, in the latest confrontation between the carmaker’s billionaire boss Elon Musk and Brussels.

The European Court of Justice published confirmation of the case, filed by Tesla’s Shanghai subsidiary, on its website on Monday without giving further details.

Tesla’s lawsuit follows similar claims filed by Germany’s BMW and several Chinese carmakers.

In October the EU imposed anti-subsidy tariffs of up to 7.8 per cent for Tesla and up to 35.3 per cent on other Chinese electric vehicle imports produced by other carmakers. The were in addition to a 10 per cent standard import tariff for the industry.

The anti-subsidy tariffs came after an EU investigation launched in 2023 on China’s unfair support for its EV industry. Brussels found that carmakers had benefited from soft loans, cheap land deals and subsidies for suppliers such as steelmakers.

About a fifth of all electric cars sold across the EU last year, or 300,000 units, were built in China. Tesla accounted for 28 per cent of Chinese-made EVs imported into the bloc in 2023, more than any other brand, according to Transport and Environment, an environmental NGO.

Tesla was hit with the lowest tariff after an individual examination by the EU found that it received the smallest amount of support from the Chinese government.

Tesla executives have said they are adjusting their import policy from China to respond to the EU tariffs. The company currently exports Model 3 vehicles from Shanghai to the EU, while it produces the Model Y in Berlin.

The legal filing gave no details about Tesla’s argument. The case against the European Commission will be heard at the General Court, the EU’s second-highest court, and the verdict can be appealed against to the ECJ. The process could take about 18 months.

European Commission trade spokesperson Olof Gill said on Monday in response to Tesla’s filing: “We’re prepared to defend our case in court as necessary.”

Musk, an adviser to US President Donald Trump and an outspoken critic of EU technology regulation, has backed the far-right Alternative for Germany party in the country’s election campaign.

New Tesla registrations fell 13 per cent year on year to 242,945 vehicles in 2024, according to Acea, the European car industry body. Musk’s political activism has been blamed for deterring some drivers from buying a Tesla, though it has made others more likely to buy one.